<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anthem Biosciences Limited has filed an initial disclosure confirming it does not fall under the Large Corporate (LC) category as per SEBI regulations. The company reported outstanding borrowing of INR 2.96 crores as of March 31, 2026. This is a routine regulatory compliance filing under SEBI Circular SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172. The disclosure includes company details, CIN, borrowing information, and confirms the LC framework is not applicable to the company.
This is a routine compliance filing with no direct impact on shareholders or stock price. The low borrowing amount (INR 2.96 Crores) indicates the company is well below the threshold for Large Corporate classification.